Flagship Harbor Advisors LLC acquired a new position in Union Pacific Co. (NYSE:UNP) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,821 shares of the railroad operator’s stock, valued at approximately $258,000.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Lenox Wealth Advisors LLC bought a new position in shares of Union Pacific in the second quarter worth approximately $105,000. Landaas & Co. WI ADV bought a new position in shares of Union Pacific in the second quarter worth approximately $133,000. Ballew Advisors Inc bought a new position in shares of Union Pacific in the first quarter worth approximately $145,000. Exane Derivatives lifted its stake in shares of Union Pacific by 85.1% in the second quarter. Exane Derivatives now owns 1,096 shares of the railroad operator’s stock worth $155,000 after buying an additional 504 shares in the last quarter. Finally, Brand Asset Management Group Inc. bought a new position in shares of Union Pacific in the second quarter worth approximately $169,000. Institutional investors and hedge funds own 80.45% of the company’s stock.
Top 10 Value Stocks To Invest In 2019: Horizon Global Corporation(HZN)
Advisors' Opinion:- [By Brian Feroldi]
Horizon Global (NYSE:HZN) reported its first-quarter results on May 3. The provider of branded towing and trailering equipment had already warned investors that it was going through tough times but promised that it would take action to fix its problems. Let's dig into the company's results to see if those actions are starting to pay off.
- [By Lisa Levin]
Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N - [By Stephan Byrd]
Get a free copy of the Zacks research report on Horizon Global (HZN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Horizon Global (NYSE:HZN) has earned an average rating of “Hold” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $15.08.
- [By Logan Wallace]
OmniTek Engineering (OTCMKTS: OMTK) and Horizon Global (NYSE:HZN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.
Top 10 Value Stocks To Invest In 2019: State Bank Financial Corporation.(STBZ)
Advisors' Opinion:- [By Logan Wallace]
State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.State Bank Financial Company Profile
- [By Max Byerly]
Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on State Bank Financial (STBZ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Value Stocks To Invest In 2019: Dynavax Technologies Corporation(DVAX)
Advisors' Opinion:- [By Ethan Ryder]
Dynavax Technologies (NASDAQ:DVAX)‘s stock had its “buy” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday. They presently have a $27.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would suggest a potential upside of 67.70% from the stock’s current price.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Dynavax Technologies (DVAX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By George Budwell]
Over the past few years, however, several beaten-down biotech stocks have ended up producing enormous gains for risk-tolerant investors. For example, Acadia Pharmaceuticals (NASDAQ:ACAD), Exelixis (NASDAQ:EXEL), and Dynavax Technologies Corporation (NASDAQ:DVAX) were all once so-called "penny stocks" that went on to rebound nicely once their lead clinical candidates made it successfully onto the market.
- [By George Budwell]
Shares of immuno-oncology and next-generation vaccine-maker Dynavax Technologies Corporation (NASDAQ:DVAX) lost 10.5% of their value in September, according to data from S&P Global Market Intelligence. What went wrong for the drugmaker last month?
- [By Keith Speights]
For Dynavax Technologies Corporation (NASDAQ:DVAX), this old adage was spot-on. Between Jan. 1 and Nov. 8, 2017, the biotech stock increased more than fivefold. Investors eagerly awaited FDA approval of Dynavax's Heplisav-B hepatitis B vaccine. After two unsuccessful attempts at approval, Heplisav-B finally won a green light from the FDA on Nov. 9. Since then, Dynavax's share price has dropped 37%.
Top 10 Value Stocks To Invest In 2019: Rare Element Resources Ltd.(REE)
Advisors' Opinion:- [By Logan Wallace]
ReeCoin (CURRENCY:REE) traded flat against the dollar during the 1-day period ending at 14:00 PM Eastern on June 27th. Over the last week, ReeCoin has traded 5% higher against the dollar. One ReeCoin coin can now be purchased for about $0.0001 or 0.00000001 BTC on popular exchanges. ReeCoin has a total market cap of $175,206.00 and $0.00 worth of ReeCoin was traded on exchanges in the last day.
Top 10 Value Stocks To Invest In 2019: New York REIT, Inc.(NYRT)
Advisors' Opinion:- [By Paul Ausick]
New York REIT Inc. (NYSE: NYRT) dropped about 0.6% Thursday to set a new 52-week low of $17.01. Shares closed at $17.11 on Wednesday and the stock’s 52-week high is $78.90. Volume was about nine times the daily average of around 100,000. The company had no specific news and managed to close with a small gain for the day.
- [By Stephan Byrd]
New York REIT Inc (NYSE:NYRT) shares hit a new 52-week low during trading on Monday . The stock traded as low as $17.46 and last traded at $17.46, with a volume of 3786 shares traded. The stock had previously closed at $17.65.
- [By Logan Wallace]
Media coverage about New York REIT (NYSE:NYRT) has been trending somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. New York REIT earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.2668688678986 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
- [By Joseph Griffin]
Media headlines about New York REIT (NYSE:NYRT) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. New York REIT earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.6379734958041 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
- [By Stephan Byrd]
New York REIT Inc (NYSE:NYRT) Director Howard Goldberg acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, October 12th. The stock was acquired at an average cost of $14.23 per share, for a total transaction of $142,300.00. Following the acquisition, the director now owns 10,000 shares of the company’s stock, valued at approximately $142,300. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
- [By Max Byerly]
New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.
Top 10 Value Stocks To Invest In 2019: Poage Bankshares, Inc.(PBSK)
Advisors' Opinion:- [By Stephan Byrd]
Poage Bankshares (NASDAQ:PBSK) announced its earnings results on Monday. The savings and loans company reported $0.21 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The company had revenue of $5.39 million for the quarter. Poage Bankshares had a negative return on equity of 4.84% and a negative net margin of 14.32%.
- [By Joseph Griffin]
News coverage about Poage Bankshares (NASDAQ:PBSK) has been trending somewhat negative on Thursday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Poage Bankshares earned a daily sentiment score of -0.06 on Accern’s scale. Accern also assigned headlines about the savings and loans company an impact score of 47.5091086029881 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Top 10 Value Stocks To Invest In 2019: Liberty Broadband Corporation(LBRDK)
Advisors' Opinion:- [By Jim Royal]
It's been more than five years since Malone's Liberty empire took a 27.3% stake in the once-beleaguered cable company for $2.6 billion. Following the deal's announcement, the stock hit $100 a share, which seems like a steal at today's prices. Currently Malone's Liberty Broadband (NASDAQ:LBRDA)(NASDAQ:LBRDK) tracking stock owns a 23.3% stake worth about $16.6 billion.
- [By Max Byerly]
Get a free copy of the Zacks research report on Liberty Broadband Corp Series C (LBRDK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Schwab Charles Investment Management Inc. lifted its holdings in Liberty Broadband Corp Series C (NASDAQ:LBRDK) by 0.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 297,059 shares of the company’s stock after acquiring an additional 798 shares during the period. Schwab Charles Investment Management Inc. owned 0.16% of Liberty Broadband Corp Series C worth $22,494,000 at the end of the most recent quarter.
- [By Stephan Byrd]
Toronto Dominion Bank increased its stake in Liberty Broadband Corp Series C (NASDAQ:LBRDK) by 45.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,646 shares of the company’s stock after acquiring an additional 3,309 shares during the period. Toronto Dominion Bank’s holdings in Liberty Broadband Corp Series C were worth $805,000 at the end of the most recent reporting period.
Top 10 Value Stocks To Invest In 2019: Huaneng Power International, Inc.(HNP)
Advisors' Opinion:- [By Ethan Ryder]
Media coverage about Huaneng Power International (NYSE:HNP) has been trending somewhat positive on Sunday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Huaneng Power International earned a news impact score of 0.04 on Accern’s scale. Accern also gave news articles about the utilities provider an impact score of 46.9751001433333 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
- [By Max Byerly]
CEMIG (NYSE:CIG) and Huaneng Power International (NYSE:HNP) are both mid-cap utilities companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.
- [By Stephan Byrd]
Huaneng Power International (NYSE: HNP) and Avangrid (NYSE:AGR) are both large-cap utilities companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
- [By Ethan Ryder]
Huaneng Power International Inc (NYSE:HNP) has been assigned an average recommendation of “Hold” from the six analysts that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company.
Top 10 Value Stocks To Invest In 2019: Sypris Solutions Inc.(SYPR)
Advisors' Opinion:- [By Lisa Levin]
Sypris Solutions, Inc. (NASDAQ: SYPR) is projected to report quarterly loss at $0.07 per share on revenue of $20.35 million.
Fusion Connect, Inc. (NASDAQ: FSNN) is expected to report quarterly loss at $0.11 per share on revenue of $36.71 million.
Top 10 Value Stocks To Invest In 2019: Seres Therapeutics, Inc.(MCRB)
Advisors' Opinion:- [By Ethan Ryder]
Seres Therapeutics Inc (NASDAQ:MCRB) CEO Roger Pomerantz sold 26,492 shares of the firm’s stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $9.33, for a total value of $247,170.36. Following the transaction, the chief executive officer now owns 297,812 shares of the company’s stock, valued at $2,778,585.96. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
- [By Shane Hupp]
Seres Therapeutics (NASDAQ:MCRB) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Tuesday.
- [By Motley Fool Transcribers]
Seres Therapeutics Inc (NASDAQ:MCRB)Q4 2018 Earnings Conference CallMarch 06, 2019, 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
No comments:
Post a Comment